• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae.八种新型β-内酰胺抗生素对耐青霉素淋病奈瑟菌的体外抗菌活性。
Antimicrob Agents Chemother. 1983 Apr;23(4):541-4. doi: 10.1128/AAC.23.4.541.
2
Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.泰国曼谷淋病奈瑟菌菌株的抗菌药敏性:1994 - 1995年
Sex Transm Dis. 1997 Mar;24(3):142-8. doi: 10.1097/00007435-199703000-00004.
3
Susceptibility of penicillinase-producing and non-penicillinase-producing strains of Neisseria gonorrhoeae isolated in Durban, South Africa, to 15 beta-lactam antibiotics.在南非德班分离出的产青霉素酶和不产青霉素酶的淋病奈瑟菌菌株对15种β-内酰胺类抗生素的敏感性。
Sex Transm Dis. 1988 Jan-Mar;15(1):30-4. doi: 10.1097/00007435-198801000-00007.
4
High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.1995年至1998年期间,古巴淋病奈瑟菌分离株的大多数菌株类型表现出对四环素和青霉素的高耐药率以及对阿奇霉素的敏感性降低。
Sex Transm Dis. 2003 May;30(5):443-8. doi: 10.1097/00007435-200305000-00012.
5
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.头孢哌酮、头孢噻肟、拉氧头孢(LY127935)、阿洛西林、美洛西林及其他β-内酰胺类抗生素对淋病奈瑟菌和流感嗜血杆菌的体外抗菌活性,包括产β-内酰胺酶菌株。
Antimicrob Agents Chemother. 1980 Apr;17(4):757-61. doi: 10.1128/AAC.17.4.757.
6
Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae in Kingston, Jamaica: 1990-1991.1990 - 1991年牙买加金斯敦淋病奈瑟菌的质粒介导抗菌耐药性
Sex Transm Dis. 1995 May-Jun;22(3):155-9. doi: 10.1097/00007435-199505000-00004.
7
Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.2000 年至 2006 年韩国淋病奈瑟菌分离株的抗菌药物耐药趋势。
Sex Transm Dis. 2011 Nov;38(11):1082-6. doi: 10.1097/OLQ.0b013e31822e60a4.
8
Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeae.诺氟沙星对耐药淋病奈瑟菌的体外活性比较
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):626-8. doi: 10.1007/BF01968143.
9
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.2011 - 2012年南京性传播疾病门诊有症状男性淋病奈瑟菌分离株的抗菌药物敏感性:对头孢曲松敏感性降低的分离株的遗传特征
BMC Infect Dis. 2014 Nov 27;14:622. doi: 10.1186/s12879-014-0622-0.
10
Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand.泰国淋病奈瑟菌的抗生素敏感性调查。
Antimicrob Agents Chemother. 1992 Aug;36(8):1682-7. doi: 10.1128/AAC.36.8.1682.

引用本文的文献

1
Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae.淋病奈瑟菌体外药敏试验的头孢唑肟解释标准。
J Clin Microbiol. 1993 Sep;31(9):2531-2. doi: 10.1128/jcm.31.9.2531-2532.1993.
2
Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.接种量对青霉素酶阳性和阴性淋病奈瑟菌对31种抗菌药物敏感性比较的影响
Antimicrob Agents Chemother. 1984 Aug;26(2):192-5. doi: 10.1128/AAC.26.2.192.
3
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
4
The potential uses of ceftriaxone.头孢曲松的潜在用途。
Eur J Clin Microbiol. 1983 Oct;2(5):485-8. doi: 10.1007/BF02013913.
5
In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.新型口服头孢菌素Ro 15-8074对淋病奈瑟菌的体外活性
Antimicrob Agents Chemother. 1985 Sep;28(3):461-3. doi: 10.1128/AAC.28.3.461.
6
Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢尼西。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1986 Sep;32(3):222-59. doi: 10.2165/00003495-198632030-00002.
7
Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.头孢雷特。对其抗菌活性、药代动力学特性及临床疗效的综述。
Drugs. 1987 Oct;34(4):411-37. doi: 10.2165/00003495-198734040-00001.
8
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.头孢曲松、头孢他美酯(Ro 15 - 8074)、头孢替安酯(Ro 19 - 5247;T - 2588)及氟罗沙星(Ro 23 - 6240;AM - 833)对淋病奈瑟菌和杜克雷嗜血杆菌的体外活性
Antimicrob Agents Chemother. 1987 Jul;31(7):1153-4. doi: 10.1128/AAC.31.7.1153.
9
In vitro activity of selected antimicrobial agents against penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.所选抗菌剂对产青霉素酶淋病奈瑟菌(PPNG)和非PPNG菌株的体外活性。
Genitourin Med. 1986 Dec;62(6):373-6. doi: 10.1136/sti.62.6.373.
10
Optimum therapy for acute pelvic inflammatory disease.急性盆腔炎的最佳治疗方法。
Drugs. 1990 Apr;39(4):511-22. doi: 10.2165/00003495-199039040-00004.

本文引用的文献

1
Kinetics and renal handling of cefonicid.头孢尼西的动力学及肾脏处理过程
Clin Pharmacol Ther. 1981 Nov;30(5):587-93. doi: 10.1038/clpt.1981.208.
2
Pharmacokinetics of ceforanide.头孢雷特的药代动力学。
Antimicrob Agents Chemother. 1982 Feb;21(2):323-6. doi: 10.1128/AAC.21.2.323.
3
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.头孢曲松(Ro 13 - 9904)的抗菌活性,一种对β-内酰胺酶稳定的头孢菌素。
Antimicrob Agents Chemother. 1981 Mar;19(3):414-23. doi: 10.1128/AAC.19.3.414.
4
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.Ro 13-9904,一种长效广谱头孢菌素:体外和体内研究
Antimicrob Agents Chemother. 1980 Dec;18(6):913-21. doi: 10.1128/AAC.18.6.913.
5
Screening of Neisseria gonorrhoeae for tolerant response to beta-lactam antibiotics.淋病奈瑟菌对β-内酰胺类抗生素耐受性反应的筛查。
Antimicrob Agents Chemother. 1981 Apr;19(4):645-8. doi: 10.1128/AAC.19.4.645.
6
In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae.Ro 13 - 9904、头孢呋辛、头孢西丁和氨苄西林对淋病奈瑟菌的体外活性。
Antimicrob Agents Chemother. 1980 Aug;18(2):355-6. doi: 10.1128/AAC.18.2.355.
7
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.羟羧氧酰胺菌素和头孢唑林:正常受试者体内的比较药代动力学
Antimicrob Agents Chemother. 1981 Apr;19(4):613-9. doi: 10.1128/AAC.19.4.613.
8
Spectinomycin as primary treatment of gonorrhea in areas of high prevalence of penicillinase-producing Neisseria gonorrhoeae.在产青霉素酶淋病奈瑟菌高流行地区,大观霉素作为淋病的一线治疗药物。
Sex Transm Dis. 1981 Jan-Mar;8(1):38-9.
9
Cefoperazone: absorption, excretion, distribution, and metabolism.头孢哌酮:吸收、排泄、分布及代谢
Clin Ther. 1980;3(Spec Issue):60-79.
10
Pharmacology of ceftizoxime compared with that of cefamandole.头孢唑肟与头孢孟多的药理学比较。
Antimicrob Agents Chemother. 1981 Sep;20(3):366-9. doi: 10.1128/AAC.20.3.366.

八种新型β-内酰胺抗生素对耐青霉素淋病奈瑟菌的体外抗菌活性。

In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae.

作者信息

Kerbs S B, Stone J R, Berg S W, Harrison W O

出版信息

Antimicrob Agents Chemother. 1983 Apr;23(4):541-4. doi: 10.1128/AAC.23.4.541.

DOI:10.1128/AAC.23.4.541
PMID:6407392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC184696/
Abstract

Increasing numbers of cases of penicillin-resistant gonorrhea necessitate the evaluation of new antibiotics for treatment of this disease. We tested the susceptibility of 92 penicillinase-producing (PP) Neisseria gonorrhoeae isolates and 88 penicillin-susceptible (PS) isolates to eight new beta-lactam antibiotics. The minimal inhibitory concentrations of these antibiotics were determined by the agar plate method. PP and PS N. gonorrhoeae isolates were susceptible to clinically achievable levels of all antibiotics tested. There were, however, marked differences among the drugs with regard to the concentration required to inhibit growth. The PP N. gonorrhoeae isolates were extremely susceptible to ceftriaxone, ceftizoxime, and cefotaxime, highly susceptible to moxalactam and cefoperazone, and less susceptible to cefoxitin, ceforanide, and cefonicid (geometric mean minimal inhibitory concentrations were 0.002, 0.003, 0.007, 0.03, 0.07, 0.6, 2.4, and 3.1 micrograms/ml, respectively). Although this in vitro study showed PP N. gonorrhoeae isolates to be comparatively more susceptible to ceftriaxone, ceftizoxime, and cefotaxime than to the other antibiotics, these results may not correlate with clinical efficacy.

摘要

对青霉素耐药的淋病病例日益增多,因此有必要评估用于治疗该病的新型抗生素。我们检测了92株产青霉素酶(PP)淋病奈瑟菌分离株和88株青霉素敏感(PS)分离株对8种新型β-内酰胺类抗生素的敏感性。这些抗生素的最低抑菌浓度通过琼脂平板法测定。PP和PS淋病奈瑟菌分离株对所测试的所有抗生素在临床可达到的水平上均敏感。然而,不同药物在抑制生长所需浓度方面存在显著差异。PP淋病奈瑟菌分离株对头孢曲松、头孢唑肟和头孢噻肟极度敏感,对拉氧头孢和头孢哌酮高度敏感,而对头孢西丁、头孢尼西和头孢雷特较不敏感(几何平均最低抑菌浓度分别为0.002、0.003、0.007、0.03、0.07、0.6、2.4和3.1微克/毫升)。尽管这项体外研究表明PP淋病奈瑟菌分离株对头孢曲松、头孢唑肟和头孢噻肟相对比对其他抗生素更敏感,但这些结果可能与临床疗效无关。